Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Confession: I Fell for HelloFresh’s ‘Free Breakfast’
A reminder to be careful about ad claims that may seem too good to be true.
Crest ‘Recycle Ready’ Toothpaste Tubes
The bottom line? Toothpaste tubes aren’t generally getting recycled.
CATrends: ‘Reef Friendly’ or ‘Reef Conscious’ Sunscreens
Lawsuits allege products contain ingredients harmful to coral reefs and marine life.
What You Should Know about Apple Cider Vinegar Supplements
TINA.org explores the divide between the marketing and the science.
HoldOn Trash Bags’ Environmental Claims
Company walks back composting claim following TINA.org inquiry sparked by self-regulatory ad challenge.